BioCentury
ARTICLE | Clinical News

Taliglucerase alfa regulatory update

December 14, 2009 8:00 AM UTC

Protalix completed submission of a rolling NDA to FDA for taliglucerase alfa to treat Gaucher's disease. The company also announced that it submitted its proposed pediatric investigation plan to EMEA ...